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Dr. Jeffery P. Koplan was the Director of the U.S. Centers for Disease Control 
and Prevention (CDC) from 1998 to 2002, and is currently the Vice President 
for Global Health at Emory University and the Director of Emory Global Health 
Institute. Dr. Koplan began his public health career in the early 1970s, and 
has worked on virtually every major public health issue, including infectious 
diseases, environmental health issues, chronic diseases and the health toll of 
tobacco, both in the United States and around the globe. Recently, Emory 
Global Health Institute received a $14 million, five-year grant from the Bill & 
Melinda Gates Foundation and established the China Tobacco Partnership 
program. Dr. Koplan is the principal investigator of the grant and is leading 
the partnership, which is devoted to reduce the burden of tobacco use in 
China. 
 
In this interview with Drs. Zheng Li and Feijun Luo, Dr. Koplan talked about the Tobacco Partnership 
program, his over 30-year of involvement in public health in China, his observation on the changes 
occurred in China, and the differences between the public health systems in the United States and 
that in China. 
 
1. Tobacco Control Partnership in China  
Zheng: Last week I heard your interview with the National Public Radio about the newly established 
China Tobacco Control Partnership. Can you tell us a little about that project? 
Dr. Koplan: It is a program that we have funding from the Bill and Melinda Gate Foundation. In 
some way it’s another chapter of the work that I have done before with the World Bank ― Health 
Loan #7 from a series of health loans that the World Bank granted to China. It was a health 
promotion project that included HIV/AIDS, also a tobacco control program in seven cities from 
late 1980s through mid-1990s. The program showed some success in cities such as Shanghai, 
Luoyang and Tianjin, which gave us some indication of the type of work that could be done on 
tobacco control in China. So with colleagues in China we obtained this grant. We currently are 
working in 17 cities, and we are working with 5 universities with the goal of establishing 
academic units that concentrate on tobacco control.  
Zheng: It sounds that this project has a longer history than the recent grant and partnership 
program?  
Dr. Koplan: Well, my own experience with tobacco control in China goes back years, and so is the 
Chinese effort on tobacco control. Therefore it has been ongoing for a while, but it certainly has 
its ups and downs over the years. There are formidable challenges, such as, as you know, the 
huge amount of smokers in China and the tobacco monopoly. Therefore, it is a huge task and 
definitely need more people than what we have currently to achieve the goal of tobacco 
control in China.  
There has been a lot of research on tobacco products and their health effects. For example, the 
Environmental Health Laboratory at CDC has been very helpful in showing the considerable 
differences in chemical components post combustion of products made in different parts of the 
world. So comparing the same brand of cigarette sold here in the U.S. to those in China or in 




Zheng: It’s a very complicated issue. 
Dr. Koplan:  On one hand, it’s not complicated at all. If you smoke, it’s bad for you, it’ll make you 
sick and it can kill you. That part is easy. But everything else is very complicated. 
2. Over 30-years of working in China on public health front 
Zheng: Judging from what you said, I can tell that you have been involved in numerous projects in 
China for many years. What made you so interested in China and how did you get started?  
Dr. Koplan: I started in 1979, so it’s been 32 years working in China, with over 50 trips to China and 
lots of collaborations. It has been very enjoyable and satisfying. My first project was the U.S.-
China collaboration on public health and health services. It came out of the initial breaking of 
the impasse between the two countries after Nixon’s visit to China in 1976. In 1979, I visited China 
as a member of an official US government team to look at potential collaborations. A year later I 
was asked to be the chairman of the team and from there it led to more involvements and 
projects. We were able to establish the primary (public health) institution in China, what was 
then the Shanghai Number One Medical College, later named Shanghai Medical University, 
now became part of the Fudan University. Prof Yang Ming-Ding, a very distinguished professor at 
Shanghai, was my counter-part. We did a lot of projects together, e.g. a scientific research study 
in Shanghai County, which at the time was a semi-rural area on the edge of the city of Shanghai, 
now it is incorporated as part of the metropolitan. That project involved multiple trips, lots of 
publication, and a whole issue of American Journal of Public Health was devoted to that study 
[1982, Volume 72, 9 Supplemental Issue]. At the same time, I started to work with the World Bank 
on many projects in China.  Then I became heavily involved in the anteceding organization of 
the China CDC -- first the National Center for Preventive Medicine, which became the Chinese 
Academy of Preventive Medicine, later became the China CDC. So I had close ties to 
administration at China CDC from the beginning.   
Feijun: So public health was one of the first top priorities between China-U.S. governments when the 
two countries just formalized their bilateral relationships in the late 1970s! 
Dr. Koplan: Yes, it was one of several focus points between the two countries. 
Feijun: Many Chinese were not aware of China CDC until the Severe Acute Respiratory Syndrome 
(SARS) outbreak in 2003. So I thought that public health was an unfamiliar concept in China 
before 2003.  
Dr. Koplan: Well, China had had major public health undertakings, such as malaria control, 
eradication of leprosy, and lots of population-wide programs that were really public health, or a 
mixture of public health and preventive medicine. For example, community level of disease 
defense started out at the “bare-foot doctors” in villages. Their roles involved not only clinical 
care, but also responsibilities such as water and sanitation which is primary public health, 
infectious diseases and vaccination program which are a mixture of clinical care and public 
health. So there has been attention on this throughout the time, even goes back to before the 
revolution. There were active public health communities in Chinese institutions before the 
liberation occurred and there has been a strong thread of public health in the past 100-120 
years of Chinese history. Sometimes it has been more prominent, and sometimes it almost 
disappeared, but it has always been there.   
3. China and Public health in China: Changes, Strength and Challenges  
Zheng: Over the past 30 years, do you see any changes in China and any changes on the public 
health front?  
Dr. Koplan: There have been remarkable changes. For one, the economic system has completely 
been revolutionized, from the Marxist Maoist economy to a free enterprise capitalist system. The 
changes occurred include the level of industrialization, the shift from government-owned 





While there are huge 
improvements on overall 
health status and life span 
[in China], there are also 
factors that affect health 
negatively. Among those 
are changing dietary 
pattern, decreased levels of 
physical activity, ongoing 
exposure to environmental 
pollutants, and tobacco 
addiction by the male 
population in the country. 
—Dr. Jeffery P. Koplan 
Emory University 
products that China is providing to the world. The growth of infrastructure in the country is 
immense and really unparallel ― roads, trains, airports, bridges and dams.  
 However, the wealth happened primarily along the east coast and southeast, and less so as you 
go further west. There is a greater urban-rural gap in development. Also in my opinion, there has 
not been a remarkable shift in gender roles, i.e., the limited role of women in business and 
government. I know that there’s saying in China that “Women hold up half of the sky”. Women 
may be holding up half sky, but they are not sitting up there at the top controlling the clouds.  
 There are changes in other fields too. From the health perspective, the epidemiologic transition 
from primarily infectious issues to more chronic diseases has occurred in most parts of the 
country. Of course in some areas such transition is far from complete, still with lots of tuberculosis 
and acute respiratory diseases. Nevertheless, the transition towards the chronic diseases is pretty 
notable in many parts. The life span in China, particularly on the eastern part of the country, is 
very much like the U.S. and other developed countries. The major causes of death, like 
everywhere else, are cancer, heart disease and stroke, etc.  
While there are huge improvements on overall health status 
and life span, there are also factors that affect health 
negatively. Among those are changing dietary pattern, 
decreased levels of physical activity, ongoing exposure to 
environmental pollutants, and tobacco addiction by the 
male population in the country. Diabetes was very hard to 
find in China 30 years ago, as was overweight or obesity. That 
has changed dramatically. There are multiple studies showing 
that people are taking in more total calories, more calories 
from fat and animal fat, and high amount of sodium. With 
these came higher incidences of heart diseases, stroke, 
diabetes, certain types of cancers, etc.  
Government policy, to some extent, has caused a reduction 
on physical activity among the population, such as 
encouraging ownership of automobile and limiting bicycle 
lanes on the roads. The shift towards automobile is huge, but 
with it came with a lot of headaches, especially from health 





Dr. Koplan receiving consultation from a Traditional Chinese 





4. Differences between the public health systems in China and the U.S.  
Zheng: How is the public health system structured in China? 
Dr. Koplan: China has a very developed public health infrastructure.  It can be a very good 
example to many other developing countries at a similar stage.  China’s public health system is 
marketed through the name of “CDC”.  There are CDCs at different levels, for example, 
Hangzhou CDC (city), Zhejiang CDC (province), and China CDC (country).  There is a good 
division of responsibility that goes from the local level to the provincial level and to the national 
level. The system has steadily improved itself over the years. At the beginning, like many other 
systems, there were many weaknesses and holes in it.  As we discussed earlier, the SARS event 
played some role in strengthening China’s public health system and catching people’s attention 
to public health.  I can tell you more in a few months since I will be reviewing China CDC as an 
external reviewer now that China CDC is 10 years old.    
Feijun: What are the strengths of public health systems in each of the two countries? 
Dr. Koplan: The U.S. has a longer time of operation and a better working relationship between 
different levels, even though there is still room for improvement.  I think in some ways there are 
more defined distinctions between services provided from (CDC headquartered in) Atlanta and 
from the state health departments.  U.S. CDC provides expertise to states.  Every state can do 
epidemiology investigations on its own, but when problems reach certain level, CDC can come 
to help.  It is very important to establish a collegial partnership between CDC staff and states 
and this is well understood by CDC teams.  It would not work well if you say “[W]e are better 
than you, we are smarter than you, and we are more sophisticated than you.”  It is important to 
develop a relationship where one side may have more expertise in an area than the other but 
does not act in a way that makes people feel bad about it.  That’s part of the reason U.S. CDC is 
successful.  CDC people cannot do investigations in states unless they are invited in by state 
health officials.  Suppose you read big news about cholera outbreak in Louisiana, you can call 
Louisiana and ask what is going on.  If they say they got the situation under control and they do 
not need you, you cannot go.  I think China CDC probably can come in without requests from 
local provinces.   
Another related factor is that U.S. CDC provides a lot of funding to state health departments.  If 
you have a chance to visit a state health department, you will find many people working there 
are on salaries, funding, or projects from CDC.  In China, the budget of China CDC is from the 
central government and the budget of Guangdong CDC is from Guangdong province.  These 
can affect the relationships between CDC at national level and local CDC or health 
departments.        
One thing I think we can learn from China is its surveillance systems.  China has set up almost 
real-time surveillance systems in many places.  If I see a patient in one of the city hospitals in 
Guangdong province, the information can be sent almost in real time electronically to 
Guangdong CDC and then to China CDC for analysis.  So the electronic surveillance system is 
much better in China.  Chinese visitors to U.S. CDC are surprised that the U.S. surveillance system 
still uses paper in some cases.   
During a recent meeting, I said to the officials of the Chinese Health Ministry in an informal way 
that their system is much better than ours for getting something done in public health, “[Y]ou 
don’t have to ask for permissions from a lot of people and you can get things done quickly.”  
They said one would think that is the case, but between Beijing and some rural areas, there are 
a lot that get dropped out. I can relate it to a saying in Qing dynasty, something like “[T]he 







5. Interest in Chinese Culture 
Feijun:  You are very familiar with Chinese culture and we heard several Chinese sayings or proverbs 
during our conversation.  Can you tell us how you feel about Chinese culture and what is your 
favorite place in China to visit? 
Dr. Koplan: I like to read Chinese history and literature, but my big regret is that I have never 
learned the language.  The more I work in China, the more I learn how little I knew before.  I 
never get tired of learning more about Chinese culture, history, and literature.  China has 
incredibly rich culture and history.  I went to the Symphony Hall in Beijing and attended music 
concerts and I like Beijing opera.  I travelled around China and visited many places and found 
many different cultural items.  I love Yunnan Province because of the minority groups who are 
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At altitude of 3600 meters outside of Xining, Qinghai, Dr. Koplan, in 
Boston Red Sox cap, meets two field workers harvesting fungi from 
hillside. One of them was wearing the cap of the New York 
Yankees, a fierce rival of Red Sox. 
